SCHEMBL3628081

SCHEMBL3628081

Cc1ccc(S(=O)(=O)CI)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ GAA P10253 2/20 0.54
▸ KMT2A Q03164 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ CTSK P43235 1/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA3 P07451 1/20 0.50
▸ CA6 P23280 1/20 0.50
▸ CA5A P35218 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CA5B Q9Y2D0 1/20 0.50
▸ TLR9 Q9NR96 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10702838 0.83 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL17577506 0.82 ALDH1A1 (0.69) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL14393403 0.81 ENPP2 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL86088 0.80 ALDH1A1 (0.67) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL63945 0.80 ALDH1A1 (0.67) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL41372 0.80 ALDH1A1 (0.82) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL8742947 0.79 ALDH1A1 (0.72) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL8788972 0.78 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL13564611 0.78 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL28321182 0.77 GAA (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104023529-B Use nitrogen polymer Stable Iodine compound 朗盛德国有限责任公司 2016-10-12 — — CN claimed
CN-104204057-B Thiabendazole and the stable compositions containing iodine antifungal 朗盛德国有限责任公司 2016-10-05 — — CN claimed
CN-1891043-A Combinations of active ingredients for protecting animal skins and leather BAYER AG (DE) 2007-01-10 — — CN claimed
US-6972133-B1 Degradable animal chewing article possessing enhanced safety, durability and mouth-feel SEEFAR TECHNOLOGIES, INC. (US) 2005-12-06 — — US claimed
CN-1701664-A Combination of active ingredients for protecting animal hides and leather BAYER AG (DE) 2005-11-30 — — CN claimed
JP-56063902-A — — None — — JP disclosed
JP-11279417-A — — None — — JP disclosed
US-11814359-B2 Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors ASTRAZENECA AB (SE) 2023-11-14 — — US disclosed
US-11186564-B2 Dual NAV1.2/5HT2a inhibitors for treating CNS disorders SUNOVION PHARMACEUTICALS INC. (US) 2021-11-30 — — US disclosed
EP-3898781-A1 SILICONE-POLYCARBONATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS Dow Silicones Corporation (US) 2021-10-27 — — EP disclosed
EP-3898779-A1 SILICONE-POLYESTER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS Dow Silicones Corporation (US) 2021-10-27 — — EP disclosed
WO-2020131706-A1 SILICONE-POLYCARBONATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS DOW SILICONES CORPORATION (US) 2020-06-25 — — WO disclosed
WO-2002037962-A1 FUNGICIDE COMPOSITION BASED ON HALOSULPHONE IN PARTICULAR FOR PACKAGING JOHNSON RICHARD C (FR) 2002-05-16 — — WO disclosed
CN-1280599-A Microbicidal powder coating composition, its preparation and use DU PONT (US) 2001-01-17 — — CN disclosed
US-6139970-A PROVIDES STAIN-INHIBITING PROTECTION TO GLASS SURFACES OF STACKED GLASS SHEETS UTILIZING ONE OR MORE WATER-SOLUBLE ORGANIC ACID DISPERSED IN A MATRIX OF A WATER-SOLUBLE POLYMER OR MIXTURES THEREOF. PAGANO CARMINE (US) 2000-10-31 — — US disclosed
EP-1044102-A1 COMPOSITION FOR COATING GLASS SHEETS Pagano, Carmine Anthony (US) 2000-10-18 — — EP disclosed
JP-H11279417-A ANTIBACTERIAL AND ANTIFUNGAL RESIN COMPOSITION SANYO ELECTRIC CO LTD 1999-10-12 — — JP disclosed
WO-1999024255-A1 COMPOSITION FOR COATING GLASS SHEETS PAGANO CARMINE ANTHONY (US) 1999-05-20 — — WO disclosed
EP-0699030-A1 MICROBICIDES BAYER AG (DE) 1996-03-06 — — EP disclosed
JP-S5663902-A ANTISEPTIC AND ANTIMILDEW AGENT HOKKO CHEM IND CO LTD 1981-05-30 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11814359-B2 Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors DPP4, DPP7, DPEP1 ALDH1A1 80/4885CYP3A4 643/4885CYP2C9 782/4885
US-11186564-B2 Dual NAV1.2/5HT2a inhibitors for treating CNS disorders SCN2A, HTR2A, HTR2C ALDH1A1 448/4885CYP3A4 1177/4885CYP2C9 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback